Who owns LYRA THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Lyra Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Lyra Therapeutics stock

Who bought or sold LYRA THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Perceptive Advisors 229k $1.5M -10% Sep 2025
 View chart
Sabby Management 175k $540k 37% Dec 2025
 View chart
Ikarian Capital 21k $65k 0% Dec 2025
 View chart
Citadel Advisors 20k $128k 100% Sep 2025
 View chart
DRW Holdings 17k $52k 100% Dec 2025
 View chart
Geode Capital Management 12k $38k 11% Dec 2025
 View chart
Artia Global Partners 8.8k $27k 100% Dec 2025
 View chart
BlackRock 2.4k $7.4k 42% Dec 2025
 View chart
Tower Research Capital 2.2k $6.7k 310% Dec 2025
 View chart
Royal Bank of Canada 1.3k $10k 20% Sep 2025
 View chart
UBS Group 675.00 $2.0k -83% Dec 2025
 View chart
FMR 406.00 $2.7k -77% Sep 2025
 View chart
EverSource Wealth Advisors 338.00 $1.0k -2% Dec 2025
 View chart
Jones Financial Companies, L.L 210.00 $647.010000 0% Dec 2025
 View chart
SBI Securities 80.00 $246.000000 0% Dec 2025
 View chart
Jpmorgan Chase & Co 27.00 $178.000200 100% Sep 2025
 View chart
Brian McDonald 23.00 $71.001000 0% Dec 2025
 View chart
Advisor Group Holdings 22.00 $67.001000 0% Dec 2025
 View chart
Bryn Mawr Trust 20.00 $62.000000 0% Dec 2025
 View chart
Bnp Paribas Arbitrage, Snc 16.00 $49.000000 0% Dec 2025
 View chart
Global Retirement Partners 15.00 $46.000500 100% Dec 2025
 View chart
CWM 1.00 $0 -96% Dec 2025
 View chart
IFP Advisors 1.00 $3.000000 -50% Dec 2025
 View chart

Who sold out of Lyra Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Vanguard Group Sep 2025 29k $190k
Signature Resources Capital Management Sep 2025 400.00 $2.6k
Fortitude Family Office Sep 2025 96.00 $626.995200